Jasbir Seehra

Director, CHIEF EXECUTIVE OFFICER · 3 filings · Latest: Apr 2, 2026

Keros Therapeutics, Inc.

Ticker	Owner	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Filing
KROS	Jasbir Seehra	Director, CHIEF EXECUTIVE OFFICER	Apr 2, 2026	Option Exercise	$0.30	55,000	$16.5K	440,708	Apr 6 8:15 PM
KROS	Jasbir Seehra	Director, CHIEF EXECUTIVE OFFICER	Feb 19, 2026	Sale	$16.17	7,015	$113.4K	385,708	Feb 20 9:15 PM